BHC Bausch Health Companies Inc.

8.598USD12.30 CAD · TSX-1.76%Mkt Cap: 3.22B USDP/E: —

Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The comp…

Institutional holders20 on file

Key Statistics

Company
Market Cap3.22B USD
Enterprise Value16.71B USD
Revenue (TTM)11.11B USD
Gross Profit7.25B USD
Net Income (TTM)157.00M USD
Revenue/Share29.73 USD
Last Price8.598 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees20.3K
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA0717341071
Valuation
P/E (Trailing)—
P/E (Forward)2.02
PEG0.02
EV/EBITDA5.73
EV/Revenue1.50
P/S0.41
P/B-2.47
EPS (TTM)-3.14 USD
EPS (Forward)6.09 USD
52W Range
4.26495% of range8.850
52W High8.850 USD
52W Low4.264 USD
Profitability
Gross Margin70.65%
Oper. Margin27.18%
EBITDA Margin37.53%
Profit Margin1.53%
ROE-28.34%
ROA0.60%
ROIC5.48%
ROCE9.85%
Growth
Revenue Growth9.70%
Earnings Growth139.60%
Cash Flow & Leverage
Operating CF1.40B USD
CapEx (TTM)407.00M USD
FCF Margin14.76%
FCF Yield50.98%
Net Debt18.23B USD
Net Debt/EBITDA4.37
Net Debt/FCF11.11
Balance Sheet
Debt/Equity-37.64
Current Ratio1.56
Quick Ratio1.06
Book Value/Sh-4.98 USD
Cash/Share6.64 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield1.39%
Payout Ratio0.00%
Ex-Div DateNov 10, 2010
Pay Date—
Splits
Last Split2:1
Split DateOct 5, 2000
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.374.27M
Float260.85M
Insiders11.12%
Institutions64.89%
Short Interest
Short Ratio6.3d
Short % Float1.46%
Short % Out.1.17%
Shares Short4.38M
Short (prev mo.)3.89M
Technical
SMA 506.618 (+29.9%)
SMA 2005.672 (+51.6%)
Beta0.28
S&P 52W Chg12.00%
Avg Vol (30d)687.47K
Avg Vol (10d)652.67K
Technical Indicators
RSI (14)68.4
MACD0.8162
MACD Signal0.8014
MACD Hist.+0.0148
BB Upper9.528 USD
BB Middle7.887 USD
BB Lower6.246 USD
BB Width41.61%
ATR (14)0.3375 USD
Vol Ratio (20d)0.59x

About Bausch Health Companies (TSE: BHC)

›

Bausch Health Companies (TSE: BHC) is listed on the Toronto Stock Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 20,300 employees.

The shares were at 12.30 CAD on 19 November 2026, up 24.5% over 52 weeks. Its 52-week range is 6.100 CAD to 12.66 CAD: the price is 2.8% below the high and 101.6% above the low.

Its market capitalisation is 4.60B CAD.

Bausch Health Companies reports return on equity of -28.3%, an operating margin of 27.2% and revenue up 9.7% year over year.

Its debt exceeds its cash by 18.23B USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. The next earnings report is expected on 17 February 2027.